1. Home
  2. MLEC vs BCTX Comparison

MLEC vs BCTX Comparison

Compare MLEC & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$7.86

Market Cap

6.5M

Sector

Finance

ML Signal

HOLD

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$3.60

Market Cap

28.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLEC
BCTX
Founded
2008
2014
Country
Cayman Islands
Canada
Employees
72
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
28.8M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
MLEC
BCTX
Price
$7.86
$3.60
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
25.5K
235.6K
Earning Date
05-12-2026
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.42
N/A
Revenue Next Year
$30.00
$380.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.61
52 Week High
$23.22
$14.68

Technical Indicators

Market Signals
Indicator
MLEC
BCTX
Relative Strength Index (RSI) 46.48 45.14
Support Level $7.18 $2.98
Resistance Level $11.48 $4.51
Average True Range (ATR) 0.85 0.31
MACD -0.12 -0.01
Stochastic Oscillator 14.34 46.69

Price Performance

Historical Comparison
MLEC
BCTX

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: